1. Home
  2. CYTH vs COCH Comparison

CYTH vs COCH Comparison

Compare CYTH & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTH
  • COCH
  • Stock Information
  • Founded
  • CYTH 1990
  • COCH 1995
  • Country
  • CYTH United States
  • COCH United States
  • Employees
  • CYTH N/A
  • COCH N/A
  • Industry
  • CYTH Biotechnology: Pharmaceutical Preparations
  • COCH Blank Checks
  • Sector
  • CYTH Health Care
  • COCH Finance
  • Exchange
  • CYTH Nasdaq
  • COCH Nasdaq
  • Market Cap
  • CYTH 31.9M
  • COCH 29.8M
  • IPO Year
  • CYTH N/A
  • COCH N/A
  • Fundamental
  • Price
  • CYTH $0.91
  • COCH $1.48
  • Analyst Decision
  • CYTH Buy
  • COCH Strong Buy
  • Analyst Count
  • CYTH 3
  • COCH 3
  • Target Price
  • CYTH $0.95
  • COCH $8.00
  • AVG Volume (30 Days)
  • CYTH 4.5M
  • COCH 26.3K
  • Earning Date
  • CYTH 03-17-2025
  • COCH 04-01-2025
  • Dividend Yield
  • CYTH N/A
  • COCH N/A
  • EPS Growth
  • CYTH N/A
  • COCH N/A
  • EPS
  • CYTH N/A
  • COCH N/A
  • Revenue
  • CYTH $870,725.00
  • COCH $278,000.00
  • Revenue This Year
  • CYTH N/A
  • COCH N/A
  • Revenue Next Year
  • CYTH $24.49
  • COCH $19.76
  • P/E Ratio
  • CYTH N/A
  • COCH N/A
  • Revenue Growth
  • CYTH N/A
  • COCH 15.35
  • 52 Week Low
  • CYTH $0.55
  • COCH $1.17
  • 52 Week High
  • CYTH $1.79
  • COCH $11.46
  • Technical
  • Relative Strength Index (RSI)
  • CYTH 53.59
  • COCH 45.07
  • Support Level
  • CYTH $0.85
  • COCH $1.39
  • Resistance Level
  • CYTH $1.45
  • COCH $1.62
  • Average True Range (ATR)
  • CYTH 0.13
  • COCH 0.13
  • MACD
  • CYTH -0.00
  • COCH 0.00
  • Stochastic Oscillator
  • CYTH 22.83
  • COCH 31.03

About CYTH Cyclo Therapeutics Inc.

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.

About COCH Envoy Medical Inc.

Envoy Medical Inc is a hearing health company focused on providing innovative medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life.

Share on Social Networks: